Uncategorized
Key Takeaways From Personalis Analyst Ratings
Latest Ratings for PSNL Date Firm Action From To Feb 2022 Oppenheimer Maintains Outperform Feb 2022 Citigroup Maintains Buy Feb 2022 HC Wainwright & Co. Maintains Buy View More Analyst Ratings for PSNL View the Latest Analyst Ratings read more
What’s Going On With Bank Of America (BAC) Shares
Bank of America shares are trading higher by 6% this week. The stock is up following news of Donald Trump’s victory in the 2024 U.S. presidential election. read more
Why Alibaba Shares Are Rising
Alibaba shares are trading higher by 4.2% Thursday afternoon. The stock is gaining amid hopes of economic stimulus from China following President-elect Donald Trump’s win. read more
Why Enphase Energy (ENPH) Shares Are Falling
Enphase Energy shares dropped 17% this week amid Donald Trump’s re-election. This has raised fears of reduced renewable subsidies and increased support for fossil fuels. read more
Sega Revives A Combat Classic: Will Virtua Fighter 6 Be The Next Big Game?
Sega confirms the development of a new Virtua Fighter game, joining other legacy revivals like Crazy Taxi and Jet Set Radio. read more
Trump’s Potential ‘Health Czar’ Robert F. Kennedy Jr. Rattles Vaccine Stocks: ‘Shoot First Reaction’
Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his “Make America Healthy Again” agenda. read more
3 Stocks Set For Major Upside From Inflation Reduction Act — Why Tesla Misses Goldman’s List
Goldman analysts highlight 9 companies with IRA exposure. Array Tech, Enphase, Nextracker projected for 114%, 75%, 58% upside, while Tesla’s gains may be modest. read more
Peeling Back The Layers: Exploring Coty Through Analyst Insights
Latest Ratings for COTY Date Firm Action From To Jan 2022 Raymond James Maintains Outperform Jan 2022 DA Davidson Upgrades Neutral Buy Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for COTY View the Latest Analyst Ratings read more
Evaluating Pacira BioSciences: Insights From 8 Financial Analysts
Latest Ratings for PCRX Date Firm Action From To Feb 2022 Wedbush Maintains Outperform Feb 2022 HC Wainwright & Co. Maintains Buy Jan 2022 Barclays Maintains Overweight View More Analyst Ratings for PCRX View the Latest Analyst Ratings read more